Antipodes Partners’s Keysight KEYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131M Sell
374,565
-4,299
-1% -$1.47M 2.4% 13
2026
Q1
$107M Sell
378,864
-42,600
-10% -$10.7M 2.06% 20
2025
Q4
$85.6M Sell
421,464
-28,990
-6% -$5.38M 1.8% 25
2025
Q3
$78.8M Sell
450,454
-277,482
-38% -$46.2M 1.77% 25
2025
Q2
$119M Sell
727,936
-207,554
-22% -$31.6M 3.7% 10
2025
Q1
$140M Buy
935,490
+309,345
+49% +$51.1M 4.39% 9
2024
Q4
$101M Buy
626,145
+462,403
+282% +$74.5M 3.5% 9
2024
Q3
$26M Buy
+163,742
New +$23.3M 0.9% 35

Other funds holding KEYS

Antipodes Partners's KEYS Position: Q2 2026 in Review

Antipodes Partners reduced its Keysight (KEYS) stake by 1.1% in Q2 2026, selling an estimated $1.47M and leaving 374,565 shares worth $131M. The position accounts for 2.4% of the portfolio, ranked #13.

Antipodes Partners first reported a position in KEYS in Q3 2024 and has held it in 8 quarters since. The position peaked at $140M in Q1 2025. 1,253 funds tracked by Wall St. Rank hold KEYS as of Q2 2026.

  • Antipodes Partners held 374,565 shares of Keysight worth $131M as of Q2 2026.
  • Antipodes Partners sold 4,299 Keysight shares in Q2 2026, an estimated $1.47M.
  • Keysight made up 2.4% of Antipodes Partners's portfolio in Q2 2026, its #13 holding.
  • Antipodes Partners first reported a position in Keysight in Q3 2024 and has held it in 8 quarters since.
  • Antipodes Partners's Keysight position peaked at $140M in Q1 2025.
  • 1,253 funds tracked by Wall St. Rank held Keysight as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.